Summary
Expression of the RB tumor suppressor gene, whose function is putatively in controlling cell growth, may be regulated by S-phase specific inhibitors of DNA synthesis that are commonly used in cell synchronization and cancer chemotherapy. Relatively low concentrations of the agents, cytosine arabinoside, bromodeoxyuridine, 5-fluorouracil, hydroxyurea, methotrexate and retinoic acid, were tested. At low concentrations still permitting submaximal cell growth, these drugs all changed RB gene expression, causing either up or down regulation of RB expression to varying degrees. Despite their potential similarity as a class, the nucleotide analogues elicited differential effects. The drug-induced up or down regulation of RB expression did not correlate with changes in c-myc expression indicating that the changes are not a manifestation of general metabolic changes potentially associated with altered proliferation. Amongst the agents considered, retinoic acid was the only one that caused a significant parallel reduction in RB and c-myc expression in the HL-60 human promyelocytic leukemia cells tested. The results thus show that even low concentrations of DNA synthesis inhibitors can have unpredictable affects on expression of growth regulatory genes.
Similar content being viewed by others
References
Castaigne, S.; Chomienne, C.; Daniel, M. T., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704–1709; 1990.
Collins, S. J.; Gallo, R. C.; Gallagher, R. E. Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270:347–349; 1977.
Evan, G. I.; Lewis, G. K.; Ramsay, G., et al. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Molecular and Cellular Biology 5:3610–3616; 1985.
Friend, S. H.; Bernards, R.; Rogelj, S., et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646; 1986.
Fung, Y.-K. T.; Murphree, A. L.; T’Ang, A., et al. Structural evidence for the authenticity of the human retinoblastoma gene. Science 236:1657–1661; 1987.
Griep, A. E.; De Luca, H. F. Studies on the relation of DNA synthesis to retinoic acid-induced differentiation of F9 teratocarcinoma cells. Exp. Cell Res. 164:223–231; 1986.
Horowitz, J. M.; Yandell, D. W.; Park, S.-H., et al. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937–940; 1989.
Lee, W. H.; Bookstein, R.; Hong, F., et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399; 1987.
Rubin, E.; Kharbanda, S.; Gunji, H., et al. Cis-diaminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase c-dependent signaling pathway. Cancer Res. 52:878–882; 1992.
Toguchida, J.; Ishizaki, K.; Sasaski, M. S., et al. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 338:156–158; 1989.
Yen, A. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hemat. Rev. 4:5–46; 1990.
Yen, A.; Forbes, M. E. C-myc down regulation and precommitiment in HL-60 cells due to bromodeoxyuridine. Cancer Res. 50:1411–1420; 1990.
Yen, A.; Chandler, S.; Sturzenegger-Varvayanis, S. Regulated expression of the RB “tumor suppressor gene” in normal lymphocyte mitogenesis: elevated expression in transformed leukocytes and role as a “status quo” gene. Exp. Cell Res. 192:289–297; 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yen, A., Varvayanis, S. RB tumor suppressor gene expression responds to DNA synthesis inhibitors. In Vitro Cell Dev Biol - Animal 28, 669–672 (1992). https://doi.org/10.1007/BF02631044
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02631044